Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes

Abstract

Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia, comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, or 30 minutes prior to initiation of exercise.

Dependencies are inferred from the claim text.